The authors showed that heregulin-induced HER2 activation resulted in phosphorylation of FAK at tyrosine 861, while six breast tumor samples exhibited increased level of phospho-Src Tyr-215 in HER2 neu-overexpressing breast cancers. Here, ERBB2 is linked to breast neoplasm.